Brian A Walker
Indiana University Bloomington
H-index: 57
North America-United States
Top articles of Brian A Walker
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Journal of Clinical Oncology
2024/1/9
Prospective Molecular Characterization of Multiple Myeloma Patient Samples Identifies High-Risk Patients and Informs Treatment Sequences through Resistance Mechanisms to …
Blood
2023/12/1
Targeting Loss of the Tumor Suppressor TENT5C in Multiple Myeloma
Blood
2023/11/28
Enze Liu
H-Index: 3
Brian A Walker
H-Index: 42
Somatic Hypermutation in Enhancer Regions Shapes Non-Coding Myeloma Genome, Generating DNA Breaks and Driving Etiology through Mutation and Structural Variation
Blood
2023/11/28
Brian A Walker
H-Index: 42
Aneta Mikulasova
H-Index: 9
Liming Hou
H-Index: 10
Sanxiong Liu
H-Index: 2
Francesco Maura
H-Index: 20
The Oligosaccharyltransferase Complex: A Novel Vulnerability in Multiple Myeloma
Blood
2023/11/28
Enze Liu
H-Index: 3
Brian A Walker
H-Index: 42
Unraveling Diverse Mechanisms of Complex Structural Variant Interactions through Multiomic Data in Multiple Myeloma
Blood
2023/11/28
Investigating the Functional Impact of CRBN Mutations on Response to IMiD/Celmod Agents in Myeloma
Blood
2023/11/28
Shannon Martin
H-Index: 9
Brian A Walker
H-Index: 42
Synergistic Effects of Type I PRMT1 and Type II PRMT5 Inhibitors Against Multiple Myeloma
Blood
2023/11/28
Enze Liu
H-Index: 3
Brian A Walker
H-Index: 42
Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
Frontiers in Immunology
2023/11/15
Brian A Walker
H-Index: 42
Multiomic mapping of acquired chromosome 1 copy-number and structural variants to identify therapeutic vulnerabilities in multiple myeloma
Clinical Cancer Research
2023/10/2
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma
Blood Cancer Journal
2023/9/11
P-345 Connecting 1q amplification and PHF19 expression in high-risk myeloma clones
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
P-179 Altered lipid metabolism in IMiD/CELMoD resistant multiple myeloma confers novel and targetable vulnerabilities
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
OA-27 Single cell transcriptomics reveals the impact of tumor cell interactions with the bone marrow immune microenvironment in the progression of multiple myeloma
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
OA-32 The impact of genomics to identify novel immunotherapeutic targets in multiple myeloma
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma
Research Square
2023/8/16
Enze Liu
H-Index: 3
Gareth Morgan
H-Index: 11
Kun Huang
H-Index: 24
Mohammad Abu Zaid
H-Index: 12
Brian A Walker
H-Index: 42
Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
Frontiers in Immunology
2023/8/4
Brian A Walker
H-Index: 42
Individualized risk stratification in newly diagnosed multiple myeloma
Cancer Research
2023/4/4
SETD2 is a novel and druggable dependency in IMiD/CELMoD resistant multiple myeloma models
Cancer Research
2023/4/4
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement
Haematologica
2023/3/3
Co-Authors
